Follow
Justin Meyerowitz
Justin Meyerowitz
Medical Director, Revolution Medicines
Verified email at stanford.edu
Title
Cited by
Cited by
Year
N-Myc drives neuroendocrine prostate cancer initiated from human prostate epithelial cells
JK Lee, JW Phillips, BA Smith, JW Park, T Stoyanova, EF McCaffrey, ...
Cancer cell 29 (4), 536-547, 2016
3562016
The prenatal origins of cancer
GM Marshall, DR Carter, BB Cheung, T Liu, MK Mateos, JG Meyerowitz, ...
Nature Reviews Cancer 14 (4), 277-289, 2014
2982014
Drugging MYCN through an allosteric transition in Aurora kinase A
WC Gustafson, JG Meyerowitz, EA Nekritz, J Chen, C Benes, E Charron, ...
Cancer cell 26 (3), 414-427, 2014
2772014
G-protein activation by a metabotropic glutamate receptor
AB Seven, X Barros-Álvarez, M de Lapeyrière, MM Papasergi-Scott, ...
Nature 595 (7867), 450-454, 2021
822021
Asymmetric activation of the calcium-sensing receptor homodimer
Y Gao, MJ Robertson, SN Rahman, AB Seven, C Zhang, JG Meyerowitz, ...
Nature 595 (7867), 455-459, 2021
742021
The tethered peptide activation mechanism of adhesion GPCRs
X Barros-Álvarez, RM Nwokonko, A Vizurraga, D Matzov, F He, ...
Nature 604 (7907), 757-762, 2022
702022
Epithelial carbonic anhydrases facilitate PCO2 and pH regulation in rat duodenal mucosa
M Mizumori, J Meyerowitz, T Takeuchi, S Lim, P Lee, CT Supuran, ...
The Journal of Physiology 573 (3), 827-842, 2006
682006
Structure determination of inactive-state GPCRs with a universal nanobody
MJ Robertson, MM Papasergi-Scott, F He, AB Seven, JG Meyerowitz, ...
Nature Structural & Molecular Biology 29 (12), 1188-1195, 2022
582022
Drug discovery in the era of cryo-electron microscopy
MJ Robertson, JG Meyerowitz, G Skiniotis
Trends in biochemical sciences 47 (2), 124-135, 2022
512022
BRAF status in personalizing treatment approaches for pediatric gliomas
A Olow, S Mueller, X Yang, R Hashizume, J Meyerowitz, W Weiss, ...
Clinical Cancer Research 22 (21), 5312-5321, 2016
452016
The oxytocin signaling complex reveals a molecular switch for cation dependence
JG Meyerowitz, MJ Robertson, X Barros-Álvarez, O Panova, ...
Nature Structural & Molecular Biology 29 (3), 274-281, 2022
362022
Structure‐Based Evolution of G Protein‐Biased μ‐Opioid Receptor Agonists
H Wang, F Hetzer, W Huang, Q Qu, J Meyerowitz, J Kaindl, H Hübner, ...
Angewandte Chemie International Edition 61 (26), e202200269, 2022
322022
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19
D Feyaerts, J Hedou, J Gillard, H Chen, ES Tsai, LS Peterson, K Ando, ...
Cell Reports Medicine 3 (7), 2022
262022
Plasticity in ligand recognition at somatostatin receptors
MJ Robertson, JG Meyerowitz, O Panova, K Borrelli, G Skiniotis
Nature Structural & Molecular Biology 29 (3), 210-217, 2022
252022
Discovery of RMC-5552, a selective bi-steric inhibitor of mTORC1, for the treatment of mTORC1-activated tumors
GL Burnett, YC Yang, JB Aggen, J Pitzen, MK Gliedt, CM Semko, ...
Journal of medicinal chemistry 66 (1), 149-169, 2022
212022
Manual of clinical anesthesiology
LF Chu, AJ Traynor, V Kurup
Lippincott Williams & Wilkins, 2020
162020
Impact of magnesium on oxytocin receptor function
VN Bharadwaj, J Meyerowitz, B Zou, M Klukinov, N Yan, K Sharma, ...
Pharmaceutics 14 (5), 1105, 2022
112022
A new “angle” on kinase inhibitor design: Prioritizing amphosteric activity above kinase inhibition
JG Meyerowitz, WA Weiss, WC Gustafson
Molecular & cellular oncology 2 (2), e975641, 2015
72015
Longitudinal clinical phenotyping of post COVID condition in Mexican patients recovering from severe COVID-19: a prospective cohort study
I Núñez, J Gillard, S Fragoso-Saavedra, D Feyaerts, L Islas-Weinstein, ...
42022
Longitudinal clinical phenotyping of post COVID condition in Mexican adults recovering from severe COVID-19: a prospective cohort study
I Núñez, J Gillard, S Fragoso-Saavedra, D Feyaerts, L Islas-Weinstein, ...
Frontiers in Medicine 10, 2023
22023
The system can't perform the operation now. Try again later.
Articles 1–20